Clarus Therapeutics Holdings (CRXT – Research Report) received a Hold rating and price target from Needham analyst Serge Belanger today. The company’s shares opened today at $0.21.
Belanger covers the Healthcare sector, focusing on stocks such as Pacira Pharmaceuticals, Amphastar Pharmaceuticals, and Verrica Pharmaceuticals. According to TipRanks, Belanger has an average return of 7.3% and a 48.63% success rate on recommended stocks.
Clarus Therapeutics Holdings has an analyst consensus of Hold.
See the top stocks recommended by analysts >>
The company has a one-year high of $31.24 and a one-year low of $0.20. Currently, Clarus Therapeutics Holdings has an average volume of 3.11M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Blue Water Acquisition Corp is a blank check company.
Read More on CRXT:
- Stock Market Today – Monday, August 22: What You Need to Know
- Enact Announces Neenu Kainth as Chief Customer Experience Officer
- GigaCloud Technology Inc Announces Closing of $41 Million Initial Public Offering with Simultaneous Full Exercise of the Over-Allotment Option
- Woodward (WWD) Receives a Hold from Barrington
- British inflation rate could hit 18% next year, Citi warns
